文献速递肝病

非酒精性脂肪性肝病与全因及病因特异性死亡率升高独立相关

Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-01-13

基于Rancho Bernardo研究队列1523名社区老年人(平均71.8岁),26.4%患非酒精性脂肪性肝病(NAFLD)。中位随访15.22年显示,NAFLD与全因死亡(HR 1.26)、心脏死亡(HR 1.33)和癌症死亡(HR 1.55)风险升高独立相关,人群归因分数分别为13.9%、6.2%和12.1%。

要点

  • 在社区老年人中,NAFLD与全因死亡风险升高26%独立相关(HR 1.26)。
  • NAFLD与心脏死亡(HR 1.33)和癌症死亡(HR 1.55)风险升高独立相关。
  • 调整危险因素后,13.9%的全因死亡、6.2%的心脏死亡和12.1%的癌症死亡可归因于NAFLD。

核心结论

  • NAFLD与全因死亡、心脏死亡和癌症死亡独立相关。
  • 必须继续提高对NAFLD的认识,并制定护理路径和公共卫生措施以减轻NAFLD负担及相关死亡率。

研究设计与样本

  • 分析Rancho Bernardo研究队列1992至1996年参与且截至2019年7月有死亡数据者。
  • 纳入1523名符合条件参与者,平均年龄71.8岁,男性39.9%,非西班牙裔白人99.3%,肥胖10.7%。
  • NAFLD采用针对美国多族裔人群改进的脂肪肝指数判定,并排除其他肝病继发原因。
  • 计算死亡风险的风险比(HR)、95%CI和人群归因分数,并进行病因特异性死亡的竞争风险分析。

主要发现

  • 404名(26.4%)参与者患有NAFLD。
  • 随访23311人年(平均15.22年,标准差8.41年),NAFLD组与非NAFLD组全因死亡分别为296例和717例。
  • NAFLD组与非NAFLD组心脏死亡分别为113例和263例,癌症死亡分别为62例和112例,肝病死亡分别为6例和2例。
  • NAFLD患者全因死亡风险较非NAFLD高26%(HR 1.26;95%CI 1.08-1.47)。
  • NAFLD患者心脏死亡风险高33%(HR 1.33;95%CI 1.04-1.70),癌症死亡风险高55%(HR 1.55;95%CI 1.11-2.15)。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing globally. We assessed independent associations of NAFLD with all-cause and cause-specific mortality in older community-dwelling adults in the United States. METHODS: Data from the Rancho Bernardo Study cohort, who participated in the research from 1992 to 1996 with mortality data (followed up to July 2019), were analyzed. NAFLD was determined by the improved Fatty Liver Index for the multiethnic US population in the absence of secondary causes of liver disease. Hazard ratios (HRs), 95% CIs, and population-attributable fractions of risk factors on mortality were calculated. Competing-risk analyses of cause-specific mortality were performed. RESULTS: Of the 1523 eligible participants (mean age, 71.8 y; 39.9% male; 99.3% non-Hispanic White; and 10.7% obese), 404 (26.4%) had NAFLD. During 23,311 person-years of follow-up evaluation (mean, 15.22 y; SD, 8.41 y), among NAFLD and non-NAFLD, there were 296 and 717 deaths from all causes, 113 and 263 cardiac deaths, 62 and 112 cancer deaths, and 6 and 2 liver deaths, respectively. NAFLD had a 26% higher all-cause mortality (HR, 1.26; 95% CI, 1.08-1.47) and a 33% (HR, 1.33; 95% CI, 1.04-1.70) and 55% (HR, 1.55; 95% CI, 1.11-2.15) higher cardiac and cancer mortality, respectively, than non-NAFLD. Population-attributable fractions showed 13.9% of deaths, 6.2% of cardiac deaths, and 12.1% of cancer deaths were attributable to NAFLD after adjustments of risk factors (sedentary lifestyle, obesity, hypertension, hyperlipidemia, diabetes). CONCLUSIONS: NAFLD is associated independently with all-cause, cardiac, and cancer mortality. Efforts must continue to raise awareness about NAFLD and develop care pathways and public health efforts to reduce NAFLD burden and associated mortality.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. de Avila L, Henry L, Paik JM, et al. Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2023. PMID: 36646233. doi:10.1016/j.cgh.2023.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。